News

Brief news reports on Tuberculosis

Funding neglected disease R&D beneficial to Europe, developing countries, report says

 

Read More →

Intellectual property policy incoherence at the African Union threatens access to medicines

In a stunning development, following an obscure vote of Heads of State at the Africa Union in 2007 (Assembly Council/AU/Dec. 138(VIII)), the AU Scientific, Technical, and Research Commission has proposed a draft statute to establish the Pan-Africa Intellectual Property Organization (PAIPO).  This proposed legislation will be presented to a meeting of the African Ministers in charge of Science and Technology on 6-12 November 2012 in the Democratic Republic of Congo.

Read More →

Romania: TB advocate travels to Brussels to urge the EU to address drug resistant TB

There is a certain absurdity about an American anthropologist traveling to Brussels to the European Union to report on drug-resistant tuberculosis and brief decision-makers on the severity of TB in Romania. While some consider TB in Romania to be a national issue, TB is never a ‘national matter’. Fighting it requires the cooperation of national governments, international organizations, public and private researchers, as well as the international corporations that produce lifesaving TB medicines and diagnostic equipment. Even in the comparatively wealthy economies of Europe, it is not well controlled.

Read More →

The 43rd Union World Conference on Lung Health will tackle issues from MDR-TB to tobacco control and raise the profile of lung disease

Read More →

FDA provides grant in support of TB vaccine development

The United States Food and Drug Administration (FDA) has awarded Aeras a $299,525 grant to support the discovery of biological and immunological biomarkers for TB vaccines. This funding will be used to continue assessments of a novel mycobacterial growth inhibition assay that could drastically reduce the time and cost of developing new vaccines against tuberculosis.

Read More →

Delamanid cuts MDR-TB deaths

Delamanid, an investigational drug to combat tuberculosis, improves outcomes and reduces mortality among patients with the multidrug resistant form of the disease.

Read More →

South Africa: MCC says no to TB drug access

South Africa’s Medicines Control Council will continue to deny compassionate access to bedaquiline that for many drug resistant patients is their last hope.

Read More →

Strategic investments for impact: Global Fund results report 2012

Global Fund supported programs have since 2002 detected and treated 9.3 million new smear-positive cases of tuberculosis.

Read More →

TB therapy and HIV tied to risk of MDR pneumococcal disease

HIV infection, tuberculosis (TB) treatment, age, and other factors raised the odds of multidrug-resistant (MDR) invasive pneumococcal disease (IPD) over a 5-year study period in South Africa before the pneumococcal vaccine era.

Read More →

African leaders embrace shared responsibility and call for innovative solutions to accelerate the response to AIDS, tuberculosis and malaria

African leaders gather to review progress made in the implementation of the 2001 Abuja Declaration on HIV/AIDS, Tuberculosis and Other Related Infectious Diseases and call for sustainable strategies to advance health towards 2015 and beyond.

Read More →

Page 486 of 576 · Total posts: 10

←First 485 486 487 Last→